Beta 2-adrenoceptor induced increase of plasma insulin levels in man: evidence of direct and indirect B-cell stimulation and liver effects.
Beta 2-Adrenoceptor stimulation is known to increase plasma levels of insulin in man. To study the mechanism behind this increase, plasma insulin, plasma C-peptide, and blood glucose responses to the beta 2-adrenoceptor agonist terbutaline were investigated in healthy humans. Terbutaline (125 micrograms i.v.) induced an increase in plasma levels of C-peptide from 0.68 +/- 0.11-0.90 +/- 0.14 nmol/l after 2 min (p less than 0.05) (n = 10). Likewise, plasma insulin concentrations increased, from 0.16 +/- 0.05-0.30 +/- 0.08 nmol/l (p less than 0.02). 20 min after terbutaline injection, plasma levels of C-peptide were 0.98 +/- 0.26 nmol/l and of insulin were 0.21 +/- 0.05 nmol/l. Calculations of the minute to minute increase of plasma levels of C-peptide and insulin during the 20 min after terbutaline injection, revealed that plasma insulin increased during the first 2 min by 59 +/- 8% of the increase of plasma C-peptide, and during the third and fourth min by 44 +/- 12% of the increase of plasma C-peptide; the difference being the liver extraction of insulin. In contrast, during min 4-10 after terbutaline injection, plasma insulin levels increased more than did plasma C-peptide levels, indicating that terbutaline inhibits the liver extraction of insulin. Blood glucose levels did not change during the first 4 min after terbutaline injection. During min 6-10 after terbutaline administration, blood glucose increased, from 4.94 +/- 0.24-5.42 +/- 0.25 mmol/l (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)